Navio MD Review

Navio MD: a compounded-tirzepatide value play with a real brand-name backstop

Navio MD is built around one clear idea: get you on tirzepatide — the same active ingredient as Mounjaro and Zepbound — at a compounded price that starts around $189 a month, while still keeping brand-name pens on the shelf if you'd rather have them or eventually need them. That makes it a sensible pick for someone who wants the most effective class of weight-loss medication without paying a four-figure pharmacy counter price, but who also wants the safety net of an FDA-approved product within the same account. If you already know you only want brand-name Ozempic or Mounjaro and price isn't a concern, you can find that almost anywhere; Navio's reason to exist is the compounded-first, brand-optional middle ground.

How the tiered pricing actually works

This is the part to read carefully, because Navio's own marketing language and its older listing don't agree. The live site is explicit: "Our tiered pricing reflects your dose, so you only pay for what you need, when you need it." In plain terms, the headline $189 is an "as low as" entry price for a starting dose — not a flat rate you'll pay forever. As you titrate up to a higher maintenance dose, the monthly cost climbs. So treat $189 as the floor, not the ceiling, and confirm what your specific maintenance dose will cost before you commit. For reference, the category median across the providers we track sits around $170 a month, so Navio's entry tier comes in below typical — the open question is only how steep your personal climb is.

The brand-name lineup is priced the same tiered way. Ozempic and Zepbound both list an "as low as" entry rate, and Mounjaro carries a high four-figure monthly price that mirrors what brand semaglutide and tirzepatide cost almost everywhere — well over a thousand dollars a month. There's no teaser or first-month promo rate here; the entry tiers are the discount, not a one-month hook.

What you can actually get, and how it's dispensed

The compounded side is tirzepatide only — there's no compounded semaglutide option, so if your heart is set on a lower-cost semaglutide route, Navio isn't the place. On the brand side you can get Ozempic, Zepbound, and Mounjaro, all dispensed through US-licensed pharmacies. Medications ship to you after a board-certified provider reviews your case; this is a telehealth flow, not a walk-in clinic.

• Compounded tirzepatide — the value option, starting near $189/mo and scaling with dose
• Brand-name Ozempic, Zepbound, and Mounjaro — for patients who want FDA-approved pens
• A starter perk — Navio states first GLP-1 orders include B12 and anti-nausea support to ease the early side-effect window
• Long daily support hours — 9am to 10pm EST, seven days a week

What genuinely sets Navio apart

Three things stand out. First is the breadth of the dispensing model: compounded and brand under one roof, across 48 states, which is wider coverage than many compounding-focused competitors. Second is the included anti-nausea and B12 support on a first GLP-1 order — a small but practical touch, since nausea is the number-one reason people quit in the first month. Third, and worth knowing going in, Navio is a broader wellness platform, not a pure weight-loss shop: it also runs a women's hormone-optimization line. That's neither good nor bad, but it tells you the company's attention is split across more than GLP-1 care.

Coverage, the company, and the fine print

Navio MD operates in 48 states. The two exceptions are Alabama and Mississippi — its own site says it doesn't currently service those two. The business runs out of St. Petersburg, Florida, and publishes a direct support phone line, which is more transparency than some telehealth brands offer. If you live in AL or MS, stop here; nothing else about the service matters because you can't use it.

Who should choose it — and who should skip it

Choose Navio if you want compounded tirzepatide at a below-median entry price, like the idea of being able to switch to brand-name pens later without changing providers, and value long daily support hours during your first nervous weeks. Skip it if you want compounded semaglutide (not offered), if you live in Alabama or Mississippi (not served), or if you need a guaranteed flat monthly price — Navio's cost rises with your dose, so budget for the climb rather than the floor.

Trust and safety

Navio MD is LegitScript verified, which is a meaningful baseline signal — LegitScript vets telehealth and pharmacy operators for licensing and compliance, and plenty of fly-by-night compounders never earn it. Navio pairs that with board-certified prescribers and US-licensed pharmacies. We have no FDA warning letters or enforcement actions on file against Navio. As with any compounded GLP-1, the usual caveat applies: compounded drugs are not FDA-approved products, so the brand-name option exists precisely for patients who want that extra layer of regulatory assurance. You can read how we weigh these factors in our scoring methodology.

The bottom line

Navio MD is a solid, honestly-positioned compounded-tirzepatide provider with a genuine brand-name fallback and unusually wide 48-state reach. The $189 headline is real but it's a starting tier, not a fixed rate — that's the single most important thing to verify before you sign up. Confirm your maintenance-dose price, make sure you're not in one of the two excluded states, and decide whether tirzepatide-only on the compounded side fits your plan. If those check out, it's a credible, LegitScript-verified option that won't lock you into a four-figure pharmacy bill.

For a side-by-side, Bodybuilding Health+ ($179/month) and RNK Health ($197/month) are the most comparable options to weigh against Navio MD.